Use of tivozanib to treat subjects with refractory cancer Grant US-11504365-B2 United States of America 22 Nov 2022
USE OF TIVOZANIB TO TREAT SUBJECTS WITH REFRACTORY CANCER Application WO-2020097106-A1 World Intellectual Property Organisation (WIPO) 14 May 2020